246 citations · 384 across the 27 of their papers we have counts for
1 paper · 1 filter
Ayon Mukherjee, Kentaro Takeda, James M. S. Wason
Early-phase combination oncology trials increasingly seek the optimal biological dose combination (OBDC) rather than a maximum tolerated dose combination, in line with the FDA's Pr…